vs
Cerence Inc.（CRNC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Cerence Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.6倍（$115.1M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -4.6%，领先388.6%），Cerence Inc.同比增速更快（126.1% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 30.3%）
Cerence Inc.是一家美国跨国软件企业，核心业务为研发面向汽车领域的人工智能语音助手技术，凭借在车载智能交互领域的技术积累，为全球多家车企提供智能化车载体验解决方案。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CRNC vs RIGL — 直观对比
营收规模更大
CRNC
是对方的1.6倍
$69.8M
营收增速更快
CRNC
高出104.9%
21.2%
净利率更高
RIGL
高出388.6%
-4.6%
两年增速更快
RIGL
近两年复合增速
30.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $115.1M | $69.8M |
| 净利润 | $-5.2M | $268.1M |
| 毛利率 | 86.3% | 91.5% |
| 营业利润率 | 25.5% | 33.2% |
| 净利率 | -4.6% | 384.0% |
| 营收同比 | 126.1% | 21.2% |
| 净利润同比 | 78.4% | 1769.2% |
| 每股收益（稀释后） | $-0.12 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRNCRIGL
| Q4 25 | $115.1M | $69.8M | ||
| Q3 25 | $60.6M | $69.5M | ||
| Q2 25 | $62.2M | $101.7M | ||
| Q1 25 | $78.0M | $53.3M | ||
| Q4 24 | $50.9M | $57.6M | ||
| Q3 24 | $54.8M | $55.3M | ||
| Q2 24 | $70.5M | $36.8M | ||
| Q1 24 | $67.8M | $29.5M |
净利润CRNCRIGL
| Q4 25 | $-5.2M | $268.1M | ||
| Q3 25 | $-13.4M | $27.9M | ||
| Q2 25 | $-2.7M | $59.6M | ||
| Q1 25 | $21.7M | $11.4M | ||
| Q4 24 | $-24.3M | $14.3M | ||
| Q3 24 | $-20.4M | $12.4M | ||
| Q2 24 | $-313.5M | $-1.0M | ||
| Q1 24 | $-278.0M | $-8.2M |
毛利率CRNCRIGL
| Q4 25 | 86.3% | 91.5% | ||
| Q3 25 | 72.6% | 93.2% | ||
| Q2 25 | 73.7% | 95.6% | ||
| Q1 25 | 77.1% | 91.7% | ||
| Q4 24 | 65.0% | 89.9% | ||
| Q3 24 | 63.7% | 85.5% | ||
| Q2 24 | 71.5% | 92.4% | ||
| Q1 24 | 69.2% | 93.1% |
营业利润率CRNCRIGL
| Q4 25 | 25.5% | 33.2% | ||
| Q3 25 | -2.9% | 40.9% | ||
| Q2 25 | -1.5% | 60.1% | ||
| Q1 25 | 22.2% | 23.9% | ||
| Q4 24 | -33.3% | 28.9% | ||
| Q3 24 | -35.1% | 25.4% | ||
| Q2 24 | -503.1% | 1.2% | ||
| Q1 24 | -389.8% | -23.6% |
净利率CRNCRIGL
| Q4 25 | -4.6% | 384.0% | ||
| Q3 25 | -22.0% | 40.2% | ||
| Q2 25 | -4.4% | 58.6% | ||
| Q1 25 | 27.8% | 21.5% | ||
| Q4 24 | -47.7% | 24.9% | ||
| Q3 24 | -37.3% | 22.5% | ||
| Q2 24 | -444.5% | -2.8% | ||
| Q1 24 | -409.8% | -27.9% |
每股收益（稀释后）CRNCRIGL
| Q4 25 | $-0.12 | $14.11 | ||
| Q3 25 | $-0.26 | $1.46 | ||
| Q2 25 | $-0.06 | $3.28 | ||
| Q1 25 | $0.46 | $0.63 | ||
| Q4 24 | $-0.57 | $0.82 | ||
| Q3 24 | $-0.49 | $0.70 | ||
| Q2 24 | $-7.50 | $-0.06 | ||
| Q1 24 | $-6.66 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.5M | $155.0M |
| 总债务越低越好 | $171.9M | $52.5M |
| 股东权益账面价值 | $150.4M | $391.5M |
| 总资产 | $602.0M | $513.6M |
| 负债/权益比越低杠杆越低 | 1.14× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CRNCRIGL
| Q4 25 | $2.5M | $155.0M | ||
| Q3 25 | $3.4M | $137.1M | ||
| Q2 25 | $5.5M | $108.4M | ||
| Q1 25 | $5.4M | $77.1M | ||
| Q4 24 | $3.9M | $77.3M | ||
| Q3 24 | $5.5M | $61.1M | ||
| Q2 24 | $5.4M | $49.1M | ||
| Q1 24 | $9.4M | $49.5M |
总债务CRNCRIGL
| Q4 25 | $171.9M | $52.5M | ||
| Q3 25 | $199.7M | $60.0M | ||
| Q2 25 | $198.8M | $60.0M | ||
| Q1 25 | $257.6M | $60.0M | ||
| Q4 24 | $256.2M | $60.0M | ||
| Q3 24 | $281.9M | $60.0M | ||
| Q2 24 | $280.4M | $60.0M | ||
| Q1 24 | $278.9M | $60.0M |
股东权益CRNCRIGL
| Q4 25 | $150.4M | $391.5M | ||
| Q3 25 | $150.7M | $117.6M | ||
| Q2 25 | $155.7M | $81.9M | ||
| Q1 25 | $149.3M | $18.6M | ||
| Q4 24 | $120.7M | $3.3M | ||
| Q3 24 | $141.1M | $-14.6M | ||
| Q2 24 | $154.2M | $-29.9M | ||
| Q1 24 | $463.4M | $-31.7M |
总资产CRNCRIGL
| Q4 25 | $602.0M | $513.6M | ||
| Q3 25 | $630.6M | $242.5M | ||
| Q2 25 | $636.8M | $206.7M | ||
| Q1 25 | $665.5M | $176.0M | ||
| Q4 24 | $617.5M | $164.0M | ||
| Q3 24 | $702.4M | $139.4M | ||
| Q2 24 | $674.0M | $128.4M | ||
| Q1 24 | $987.1M | $126.5M |
负债/权益比CRNCRIGL
| Q4 25 | 1.14× | 0.13× | ||
| Q3 25 | 1.33× | 0.51× | ||
| Q2 25 | 1.28× | 0.73× | ||
| Q1 25 | 1.73× | 3.23× | ||
| Q4 24 | 2.12× | 18.25× | ||
| Q3 24 | 2.00× | — | ||
| Q2 24 | 1.82× | — | ||
| Q1 24 | 0.60× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $37.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $35.6M | — |
| 自由现金流率自由现金流/营收 | 31.0% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $74.6M | — |
8季度趋势，按日历期对齐
经营现金流CRNCRIGL
| Q4 25 | $37.9M | $22.0M | ||
| Q3 25 | $12.8M | $24.0M | ||
| Q2 25 | $23.7M | $30.5M | ||
| Q1 25 | $15.5M | $-893.0K | ||
| Q4 24 | $9.3M | $14.5M | ||
| Q3 24 | $6.1M | $21.7M | ||
| Q2 24 | $12.9M | $302.0K | ||
| Q1 24 | $1.0M | $-5.0M |
自由现金流CRNCRIGL
| Q4 25 | $35.6M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $16.1M | — | ||
| Q1 25 | $13.1M | — | ||
| Q4 24 | $7.9M | — | ||
| Q3 24 | $4.7M | — | ||
| Q2 24 | $12.1M | — | ||
| Q1 24 | $-801.0K | — |
自由现金流率CRNCRIGL
| Q4 25 | 31.0% | — | ||
| Q3 25 | 16.1% | — | ||
| Q2 25 | 25.8% | — | ||
| Q1 25 | 16.8% | — | ||
| Q4 24 | 15.5% | — | ||
| Q3 24 | 8.5% | — | ||
| Q2 24 | 17.1% | — | ||
| Q1 24 | -1.2% | — |
资本支出强度CRNCRIGL
| Q4 25 | 2.0% | — | ||
| Q3 25 | 5.0% | — | ||
| Q2 25 | 12.3% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 2.6% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 2.7% | — |
现金转化率CRNCRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | 0.71× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRNC
| License | $87.8M | 76% |
| Connected Services | $14.5M | 13% |
| Professional Services | $12.8M | 11% |
RIGL
暂无分部数据
